Schedule 13G ownership disclosure

Palvella Therapeutics Inc

Common stock, $0.001 par value per share · CUSIP: 697947109

Event date: 2024-12-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SUVRETTA CAPITAL MANAGEMENT, LLC

    Shares: 714,463.00 · Class: 8.6%

  • Averill Master Fund, Ltd.

    Shares: 714,463.00 · Class: 8.6%

  • Aaron Cowen

    Shares: 714,463.00 · Class: 8.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-24-007251
Form type
SCHEDULE 13G
Filer
PALVELLA THERAPEUTICS, INC.
CIK
CIK 1583648
Filed
Dec 20, 2024
Reporting period
Dec 13, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub